Neal Cutler, M.D., Chief Executive Officer of Worldwide Clinical Trials, has been named by the 2017 European CEO Awards as the “Best CEO in the CRO Industry.”
This honor recognizes Cutler’s contributions as the founder and CEO of Worldwide, one of the world’s leading, full-service contract research organizations (CROs). The annual European CEO Awards highlight the achievements of CEOs across a variety of industries whose contributions are driving their companies forward.
Dr. Cutler, a board-certified psychiatrist who is also board-qualified in both neurology and clinical pharmacology, has been instrumental in the design and clinical development of nearly 200 compounds in numerous therapeutic areas. Since creating the first iteration of Worldwide Clinical Trials 30 years ago, he has guided the company with a steadfast commitment to the medicine and science of clinical research, leading to impressive growth. This, along with his consistent dedication to Worldwide’s customers, were named as key reasons for his receiving the European CEO Award.
“I am humbled to have been recognized with this prestigious honor. This truly is a reflection of what Worldwide has achieved, and the high-quality service that we consistently deliver – I share this award with our amazing team,” Dr. Cutler said. “My passion for the potentially life-changing work Worldwide does every day drives me and shapes my leadership, and it is this passion that I share with our entire company. This drive to support our sponsor partners in drug discovery permeates our company and has helped build our reputation as one of the world’s leading CROs.”